国产胆道金属支架的临床应用  

The clinical application of domestic biliary metallic stents

作　　者：罗祖炎[1] 陈方宏[1] 袁建华[1] 俞文强[1] 刘子江[1] 

机构地区：[1]杭州浙江省人民医院放射科,310014

出　　处：《介入放射学杂志》2004年第5期433-435,共3页Journal of Interventional Radiology

摘　　要：目的　探讨国产胆道金属支架应用的安全性及临床疗效。方法　对 72例 (70例恶性 ,2例良性 )阻塞性黄疸患者施行经皮经肝穿刺植入国产胆道金属支架 75枚。结果　 6 6例胆道金属支架植入成功 ,技术成功率 92 .7% (6 6 72 )。支架植入术后 1个月内黄疸缓解率 97.0 % (6 4 6 6 ) ,30d内死亡 2例 ,早期并发症发生率 7.6 % (5 6 6 )。 4 4例随访 2～ 2 4个月 ,随访率 6 6 .7%。 4 2例恶性患者 ,随访 5～ 16个月 (平均 11.6个月 ) ,9例存活 ,33例死亡 ;生存时间 2～ 2 3个月 ,中位生存期 5 .3个月。随访 3、6、12个月的支架通畅率分别为 92 .8%、89.9%、79.4 %。支架再阻塞率 14 .3% (6 4 2 ) ,中位阻塞期 3个月。 2例良性梗阻患者 ,1例支架术后 2 4个月仍通畅 ,1例术后 3个月因其他原因死亡。结论　国产胆道金属支架使用方便 ,临床应用安全可靠 ,具有临床推广价值。Objective To determine the clinical efficacy and safety of domestic biliary metallic stents in the management of biliary obstruction. Methods 75 domestic biliary metallic stents were implanted in 66 of 72 patients with obstructive jaundice due to malignant (n=70) and benign stenoses (n=2). Results The technical successful rate was 92.7% (64/66). Palliation with rid of jaundice was achieved in 96.9% (64/66) within 1 month. The 30-day mortality rate was 3% (2/66). Early complications occurred in 7.6% (5/66). 44 patients were followed from 2 to 24 months after treatment. 33 (33/42) of 42 patients with malignancy died after a median survival of 5.3 months (range 2-23 months). The remaining 9 patients (9/42) remained alive with a mean follow-up of 11.6 months. The stent patency rates were 92.8%,89.9% and 79.4% at 3,6,12 months respectively. 6 patients (6/42) presented stent occlusion within a median period of 3 months. One of two patients with benign stenoses sustained a patency duration time of 24 months. One patient died 3 months after treatment. Conclusions The domestic biliary metallic stent implantation is efficacy and safety in the management of biliary obstruction.

关 键 词：胆道金属支架 临床应用 安全性 黄疸 引流术 

分 类 号：R575[医药卫生—消化系统]